Royalty Pharma（納斯達克股票代碼：RPRX）報告季度每股收益爲$1.16，超過分析師一致預期的$1.05，增幅爲10.48%。與去年同期每股收益$1.15相比，這增長了0.87%。公司報告季度銷售額爲$5.94億，未達到分析師一致預期的$6.78億，相差12.50%。與去年同期銷售額$5.96億相比，下降了0.34%。

以上內容來自Benzinga Earnings專欄，原文如下：

Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.05 by 10.48 percent. This is a 0.87 percent increase over earnings of $1.15 per share from the same period last year. The company reported quarterly sales of $594.00 million which missed the analyst consensus estimate of $678.89 million by 12.50 percent. This is a 0.34 percent decrease over sales of $596.00 million the same period last year.